76 FR 77 pg. 22322 - Medical Devices; Immunology and Microbiology Devices; Classification of Ovarian Adnexal Mass Assessment Score Test System; Correction
Type: RULEVolume: 76Number: 77Page: 22322
Docket number: [Docket No. FDA-2010-N-0026]
FR document: [FR Doc. 2011-9649 Filed 4-20-11; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 866
[Docket No. FDA-2010-N-0026]
Medical Devices; Immunology and Microbiology Devices; Classification of Ovarian Adnexal Mass Assessment Score Test System; Correction
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule; correction.
SUMMARY:
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of March 23, 2011 (76 FR 16292). The document announced the classifying of ovarian adnexal mass assessment score test system into class II (special controls). The document was published with an incorrect docket number. This document corrects that error.
DATES:
Effective: April 22, 2011.
FOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy, Planning and Budget, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.
SUPPLEMENTARY INFORMATION:
In FR Doc. 2011-6620, appearing on page 16292, in the Federal Register of Wednesday, March 23, 2011, the following correction is made:
1. On page 16292, in the first column, in the Docket No. heading, "[Docket No. FDA-2011-N-0026]" is corrected to read "[Docket No. FDA-2010-N-0026]."
Dated: April 13, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-9649 Filed 4-20-11; 8:45 am]
BILLING CODE 4160-01-P